Letters
Primary percutaneous coronary intervention
Authors’ reply to Sharvill and Beales
BMJ 2018; 360 doi: https://doi.org/10.1136/bmj.j5614 (Published 11 January 2018) Cite this as: BMJ 2018;360:j5614- Hasnain M Dalal, honorary clinical associate professor1,
- Manish M Gandhi, consultant cardiologist2,
- Christos Voukalis, clinical research fellow in cardiology3,
- Fatima Dalal, FY2 doctor4
- 1University of Exeter Medical School (Primary Care), Truro Campus, Truro TR1 3HD, UK
- 2Cardiac Department, Royal Devon and Exeter NHS Foundation Trust, Exeter EX2 5DW, UK
- 3Institute of Cardiovascular Sciences, University of Birmingham, Birmingham B15 2TT, UK
- 4Queen Elizabeth Hospital, Birmingham B15 2GW, UK
- hmdalal{at}doctors.net.uk
We thank Sharvill and Beales for drawing attention to gastroprotection for dyspepsia associated with dual antiplatelet therapy and a higher bleeding risk in elderly people, which we referred to in our article.123 We agree that a proton pump inhibitor or H2 receptor antagonist should be used to reduce the risk of bleeding in patients with a history of bleeding in the upper gastrointestinal tract and should …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.